Hypoadiponectinemia: A common basis for diseases associated with overnutrition

Current Atherosclerosis Reports

Volumn 8, Issue 5, 2006, Pages 433-438

  Funahashi, Tohru ^a   Matsuzawa, Yuji ^b  

^a OSAKA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CHOLESTEROL ESTER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; COMPLEMENTARY DNA; CYTOKINE; HORMONE; LOW DENSITY LIPOPROTEIN; PROTEIN KINASE B; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; BIOACCUMULATION; BREAST CANCER; CHEMOSENSITIVITY; COLON CANCER; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HEART FAILURE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; INTIMA; NONHUMAN; OVERNUTRITION; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; UTERUS CANCER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ADIPONECTIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; OVERNUTRITION; PROGNOSIS; RISK FACTORS;

EID: 33748435483     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-006-0042-8     Document Type: Review

References (48)

1. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdf. Accessed May 12, 2006.
2. Kissebah AH, Vydelingum N, Murray R, et al.: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982, 54:254-260.
3. Larsson B, Svardsudd K, Welin L, et al.: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J Clin Res Ed 1984, 288:1401-1404.
4. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54-59.
5. Nakamura T, Tokunaga K, Shimomura I, et al.: Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994, 107:239-246.
6. Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989, 149:1514-1520.
7. Funahashi T, Nakamura T, Shimomura I, et al.: Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999, 38:202-206.
8. Maeda K, Okubo K, Shimomura I, et al.: cDNA cloning and expression of a novel adipose specific collagen-like factor, apMa (Adipose Most Abundant gene transcript 1). Biochem Biophys Res Commun 1996, 221: 286-289.
9. Arita Y, Kihara S, Ouchi N, et al.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
10. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease? Diabetes 1988, 37:1595-1607.
11. Maeda K, Okubo K, Shimomura I, et al.: Analysis of an expression profile of genes in the human adipose tissue. Gene 1997, 190:227-235.
12. Shimomura I, Funahashi T, Takahashi M, et al.: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996, 2:800-803.
13. Ryo M, Nakamura T, Kihara S, et al.: Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68:975-981.
14. Okamoto Y, Arita Y, Nishida M, et al.: An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000, 32:47-50.
15. Ouchi N, Kihara S, Arita Y, et al.: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein, adiponectin. Circulation 1999, 100:2473-2476.
16. Ouchi N, Kihara S, Arita Y, et al.: Adiponectin, adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through cAMP-dependent pathway. Circulation 2000, 102:1296-301.
17. Arita Y, Kihara S, Ouchi N, et al.: Adipocyte-derived plasma protein, adiponectin, acts as a platelets growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002, 105:2893-2898.
18. Ouchi N, Kihara S, Arita Y, et al.: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103:1057-1063.
19. Matsuda M, Shimomura I, Sata M, et al.: Role of adiponectin in preventing vascular stenosis - the missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487-37491.
20. Okamoto Y, Kihara S, Ouchi N, et al.: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106:2767-2770.
21. Weyer C, Funahashi T, Tanaka S, et al.: Hypoadiponectinemia in obesity and type 2 diabetes: Evidence for a role of insulin resistance and/or hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
22. Hotta K, Funahashi T, Bodkin NL, et al.: Circulating concentrations of the adipocyte protein, adiponectin, are decreased in parallel with reduced insulin sensitivity during the progression to type-2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133.
23. Maeda N, Shimomura I, Kishida K, et al.: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002, 8:731-737.
24. Lindsay RS, Funahashi T, Hanson RL, et al.: Adiponectin protects against development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
25. Ouchi N, Ohishi M, Kihara S, et al.: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003, 42:231-234.
26. Ouchi N, Kobayashi H, Kihara S, et al.: Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004, 279:1304-1309.
27. Chen H, Montagnani M, Funahashi T, et al.: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278:45021-45026.
28. Iwashima Y, Katsuya T, Ishikawa K, et al.: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004, 43:1318-1323.
29. Ohashi K, Kihara S, Ouchi N, et al.: Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006, 47:1108-1116.
30. Shibata R, Ouchi N, Ito M, et al.: Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004, 10:1384-1389.
31. Shibata R, Sato K, Pimentel DR, et al.: Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005, 11:1096-1103.
32. Yokota T, Oritani K, Takahashi I, et al.: Adiponectin, a novel member of soluble defense collagens, negatively regulates the growth of myelo-monocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.
33. Ouchi N, Kihara S, Funahashi T, et al.: Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107:671-674.
34. Kumada M, Kihara S, Ouchi N, et al.: Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004, 109:2046-2049.
35. Miyoshi Y, Funahashi T, Kihara S, et al.: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003, 9:5699-5704.
36. Mantzoros C, Petridou E, Dessypris N, et al.: Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004, 89:1102-1107.
37. Dal Maso L, Augustin LS, Karalis A, et al.: Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004, 89:1160-1163.
38. Petridou E, Mantzoros C, Dessypris N, et al.: Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003, 88:993-997.
39. Goktas S, Yilmaz MI, Caglar K, et al.: Prostate cancer and adiponectin. Urology 2005, 65:1168-1172.
40. Wei EK, Giovannucci E, Fuchs CS, et al.: Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005, 97:1688-1694.
41. Kondo H, Shimomura I, Matsukawa Y, et al.: Association of adiponectin/ ACRP30/AdipoQ mutation with type 2 diabetes mellitus: a candidate gene for the insulin resistance syndrome. Diabetes 2002, 51:2325-2358.
42. Ohashi K, Ouchi N, Kihara S, et al.: Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 2004, 43:1195-1200.
43. Kishida K, Nagaretani H, Kondo H, et al.: Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochem Biophys Res Commun 2003, 306:286-292.
44. Kamada Y, Tamura S, Kiso S, et al.: Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003, 125:1796-1807.
45. Kumada M, Kihara S, Sumitsuji S, et al.: for Osaka CAD Study Group: Association of hypo-adiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
46. Zoccali C, Mallamaci F, Tripepi G, et al.: Adiponectin, the most abundant adipocyte-derived protein, is functionally related to metabolic risk factors and predicts cardiovascular outcomes in end stage renal disease. J Am Soc Nephrol 2002, 13:134-141.
47. Pischon T, Girman CJ, Hotamisligil et al.: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
48. Efstathiou SP, Tsioulos DI, Tsiakou AG, et al.: Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005, 36:1915-1919.